Brief: Iveric Bio Reports Q3 Loss Of 35 Cents Per Share
Nov 3 (Reuters) - Iveric Bio Inc ISEE.O :
* IVERIC BIO REPORTS THIRD QUARTER 2022 OPERATIONAL
HIGHLIGHTS AND
FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.35
* Q3 EARNINGS PER SHARE VIEW $-0.40 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw1tbpBYa
Further company coverage: ISEE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini